Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_assertion type Assertion NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_head.
- NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_assertion description "[Approximately 10% of patients with breast cancer who are treated with breast-conserving surgery (BCS) develop an ipsilateral-breast tumor recurrence (IBTR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_provenance.
- NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_assertion evidence source_evidence_literature NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_provenance.
- NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_assertion SIO_000772 19649554 NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_provenance.
- NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_assertion wasDerivedFrom befree-20140225 NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_provenance.
- NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_assertion wasGeneratedBy ECO_0000203 NP533722.RAeq34P5n-MPlRoP2i-0JNyh87QudkFt2lwnx5e5hD3-A130_provenance.